Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription 04.08.2025 4 BMC Cancer 2 Br J Cancer 2 Cancer Res 2 Childs Nerv Syst 1 Clin Cancer Res 5 Clin Neuropathol 1 Eur J Cancer 1 Int J Radiat Oncol Biol Phys 10 J Neurooncol 3 J Neurosurg 14 Neuro Oncol 1 Neurol Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. OLAYODE OO, Ogunoye BT, Oladeji EO, Olayinka OE, et al
   Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods.
   BMC Cancer. 2025;25:1246.
   PubMed         Abstract available
   
   
2. MINIERE HJM, Hormuth DA 2nd, Lima EABF, Farhat M, et al
   A data assimilation framework for predicting the spatiotemporal response of high-grade gliomas to chemoradiation.
   BMC Cancer. 2025;25:1239.
   PubMed         Abstract available
   
   
3. LI F, Li Z, Xu H, Kong G, et al
   Prediction of 1p/19q state in glioma by integrated deep learning method based on MRI radiomics.
   BMC Cancer. 2025;25:1228.
   PubMed         Abstract available
   
   
4. CHEN Z, Tang C, Ma X, Tian P, et al
   Efficacy and safety analysis of lorlatinib for ALK-positive advanced NSCLC: a multicentre real-world study in China.
   BMC Cancer. 2025;25:1216.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. GE Y, Yu M, Chang T, Wang Z, et al
   Predictive efficacy and role of 2HG in MGMT promoter methylation in gliomas: a retrospective study based on MRS and mediator variable analysis.
   Br J Cancer. 2025 Jul 30. doi: 10.1038/s41416-025-03132.
   PubMed         Abstract available
   
   
6. ERJAN A, Jamora K, Gutierrez E, Santiago A, et al
   Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis.
   Br J Cancer. 2025 Jul 26. doi: 10.1038/s41416-025-03111.
   PubMed         Abstract available
   
   

   
   Cancer Res

7. LIU G, Zhang H, Chen S, Gao J, et al
   Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells.
   Cancer Res. 2025 Jul 25. doi: 10.1158/0008-5472.CAN-25-0419.
   PubMed         Abstract available
   
   
8. RICHMAN CM, Rasnitsyn A, Holgado BL, Vladoiu M, et al
   Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiation Therapy.
   Cancer Res. 2025 Jul 25. doi: 10.1158/0008-5472.CAN-24-3894.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

9. BUBENIKOVA A, Haratek K, Taborska J, Trkova K, et al
   Long-term prognosis and treatment outcomes in infantile and neonatal brain tumors.
   Childs Nerv Syst. 2025;41:251.
   PubMed         Abstract available
   
   
10. BEURIAT PA, Boukaka RG, Szathmari A, Vasiljevic A, et al
    Benign brainstem tumors in children: a retrospective series of 42 patients treated in Lyon.
    Childs Nerv Syst. 2025;41:249.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

11. FAROUK SAIT S, O'Donohue TJ, Bale T, Bowman A, et al
    Improving Global Access to Genomic Profiling in Rare Pediatric Cancers.
    Clin Cancer Res. 2025;31:3285-3295.
    PubMed         Abstract available
    
    

    
    Clin Neuropathol

12. MEZMEZIAN MB, Arakaki N, Diez B, Martinetto H, et al
    Impact of 10q loss, CDKN2A deletions, EGFR amplification, and trisomy of chromosome 7 in the overall survival of IDH-mutant astrocytoma.
    Clin Neuropathol. 2025;44:136-142.
    PubMed         Abstract available
    
    
13. VENKATAPPA HA, Rao S, Mahadevan A, Kodaiyarasan P, et al
    Primary intracranial smooth muscle tumors in immunocompromised patients.
    Clin Neuropathol. 2025;44:153-158.
    PubMed         Abstract available
    
    
14. PHOM MH, Das S, Charan BD, Suri V, et al
    Intracranial mesenchymal tumor with EWSR1-rearrangement (FET::CREB family): A case series with clinico-radiological and pathological correlation and review of literature.
    Clin Neuropathol. 2025;44:159-168.
    PubMed         Abstract available
    
    
15. BUCCOLIERO AM, Giunti L, Ponticelli A, Innocenti L, et al
    Clinico-pathological and molecular characteristics of pediatric-juvenile pituitary neuroendocrine tumors (PitNETs): A mono-institutional series.
    Clin Neuropathol. 2025;44:143-152.
    PubMed         Abstract available
    
    
16. SALLE H, Durand S, Duchesne M, Lemnos L, et al
    Influence of clinical and histological criteria on meningioma recurrence: The decisive role of Ki-67.
    Clin Neuropathol. 2025 Jul 30. doi: 10.5414/NP301681.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

17. CAILLOT R, Blom A, Lebbe C, Da Meda L, et al
    Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.
    Eur J Cancer. 2025;227:115637.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

18. HORMUTH DA 2ND, Farhat M, Panthi B, Langshaw H, et al
    Forecasting chemoradiation response mid-treatment for high-grade gliomas through patient-specific biology-based modeling.
    Int J Radiat Oncol Biol Phys. 2025 Jul 25:S0360-3016(25)06020.
    PubMed         Abstract available
    
    

    
    J Neurooncol

19. PICHARDO-ROJAS PS, Bandopadhay J, Nunez LC, Dono A, et al
    Impact of maximal and supramaximal resections on postoperative diffusion-weighted imaging changes and clinical outcomes in IDH-wildtype glioblastoma.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05169.
    PubMed         Abstract available
    
    
20. MATSUDA R, Takatani T, Hayashi H, Matsuoka R, et al
    Intraoperative neuromonitoring with direct cortical stimulation motor-evoked potentials in supratentorial glioma surgeries with preoperative moderate-to-severe motor weakness.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05185.
    PubMed         Abstract available
    
    
21. LARIBI L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, et al
    Correction to: Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05147.
    PubMed        
    
    
22. GARCIA CR, Highsmith K, Knight S, Andrade IP, et al
    Single center experience of IDH inhibitors in recurrent high-grade gliomas.
    J Neurooncol. 2025 Aug 1. doi: 10.1007/s11060-025-05183.
    PubMed         Abstract available
    
    
23. HAGAN AJ, Hill RM, Kingston A, Bailey S, et al
    The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05177.
    PubMed         Abstract available
    
    
24. BEVER N, Shukla IY, Ebada A, Wan B, et al
    Disparities in meningioma resection outcomes: a retrospective analysis of patients with public versus private insurance.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05179.
    PubMed        
    
    
25. LAN TL, Lin CF, Lee YY, Chang FC, et al
    Recurrent meningioma treated with boron neutron capture therapy: a feasibility study with dosimetric and clinical correlates.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05184.
    PubMed         Abstract available
    
    
26. JAIN TK, Vohra M, Sharma BS, Loyal A, et al
    Is 18F-PSMA PET/CT a reliable imaging modality to evaluate the status of recurrent/residual brain tumors in post-treatment patients?
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05167.
    PubMed         Abstract available
    
    
27. BANDOPADHAY J, Pichardo-Rojas PS, Cho R, Tavakkol E, et al
    Assessment of the RANO-resect criteria in elderly patients with glioblastoma.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05168.
    PubMed         Abstract available
    
    
28. CHEN D, Ye L, Yu Z, Lei T, et al
    Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases.
    J Neurooncol. 2025 Jul 29. doi: 10.1007/s11060-025-05061.
    PubMed         Abstract available
    
    

    
    J Neurosurg

29. GUO X, Patel RV, Lederer JA, Meredith DM, et al
    Ki-67 in meningioma: distribution and implications.
    J Neurosurg. 2025 Jul 25:1-11. doi: 10.3171/2025.4.JNS25438.
    PubMed         Abstract available
    
    
30. HANI L, Hakim A, Gehrig L, Staruch M, et al
    Identification and relevance of ultra-early progression after resection of glioblastoma.
    J Neurosurg. 2025 Jul 25:1-10. doi: 10.3171/2025.3.JNS242212.
    PubMed         Abstract available
    
    
31. HU W, Zhao C, Zheng W, Lin Y, et al
    Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor.
    J Neurosurg. 2025 Aug 1:1-14. doi: 10.3171/2025.4.JNS243146.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

32. DEAN F, Henrikson H, Xu R, Farah H, et al
    Challenges in determining the global burden of non-malignant central nervous system tumors: An analysis of international incidence and mortality data sources.
    Neuro Oncol. 2025;27:1654-1664.
    PubMed         Abstract available
    
    
33. AHMED KA, Kim Y, Armaghani AJ, Arrington JA, et al
    Phase II trial of brain MRI surveillance in stage IV breast cancer.
    Neuro Oncol. 2025;27:1550-1558.
    PubMed         Abstract available
    
    
34. DAS D, Iyer M, Nakamura B, Sedighi S, et al
    Tumor cells upregulate neurotransmitter GABA in the choroid plexus through STAT6-Bestrophin1 signaling, promoting leptomeningeal dissemination.
    Neuro Oncol. 2025;27:1476-1490.
    PubMed         Abstract available
    
    
35. FAN C, Hu Y, Teng C, Lv Y, et al
    Intrathecal sintilimab for leptomeningeal metastases of non-small cell lung cancer failed from targeted therapy and intrathecal chemotherapy (LMIS study).
    Neuro Oncol. 2025;27:1559-1566.
    PubMed         Abstract available
    
    
36. DE SOUSA GR, Calzadilla AJ, Grimaldo E, Donson AM, et al
    Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth.
    Neuro Oncol. 2025;27:1597-1610.
    PubMed         Abstract available
    
    
37. WACH J, Basaran AE, Vychopen M, Tihan T, et al
    Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and von Hippel-Lindau disease: A multicenter study.
    Neuro Oncol. 2025;27:1567-1578.
    PubMed         Abstract available
    
    
38. ZHAO J, Wu L, Cai G, Ou D, et al
    Targeting PGE2 mediated senescent neuron improves tumor therapy.
    Neuro Oncol. 2025;27:1491-1506.
    PubMed         Abstract available
    
    
39. GALLDIKS N, Tonn JC, Preusser M, Albert NL, et al
    Update to the RANO Working Group and EANO recommendations for the clinical use of PET imaging in gliomas.
    Neuro Oncol. 2025 Jul 28:noaf170. doi: 10.1093.
    PubMed        
    
    
40. PERREAULT S, Geurts M, Mahdi J, Schreck KC, et al
    Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas.
    Neuro Oncol. 2025 Jul 26:noaf164. doi: 10.1093.
    PubMed        
    
    
41. 
    Erratum to: Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
    Neuro Oncol. 2025 Jul 28:noaf167. doi: 10.1093.
    PubMed        
    
    
42. MATSUMOTO Y, Singh O, Garcia J, Abdullaev Z, et al
    Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic Signatures.
    Neuro Oncol. 2025 Jul 28:noaf175. doi: 10.1093.
    PubMed         Abstract available
    
    
43. JOST-ENGL J, Ketter R, Brandt R, Volker K, et al
    Enhancing Cardiorespiratory Fitness and Quality of Life in High-Grade Glioma through an Intensive Exercise Intervention during Chemotherapy: Proof of Concept.
    Neuro Oncol. 2025 Jul 25:noaf176. doi: 10.1093.
    PubMed         Abstract available
    
    
44. YEI J, Lee NK, Ryu S, Ryu SE, et al
    Glioma-Associated Microglia Potentiate Neuronal Hyper-Excitability in the Glioma Environment.
    Neuro Oncol. 2025 Jul 30:noaf181. doi: 10.1093.
    PubMed         Abstract available
    
    
45. EL SHAFIE RA, Bernhardt D, Welzel T, Schiele A, et al
    Hypofractionated Stereotactic Radiotherapy versus Whole-Brain Radiotherapy following Brain Metastasis Resection - Results of the ESTRON Randomized Phase 2 Trial.
    Neuro Oncol. 2025 Jul 30:noaf182. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

46. YIN J, Zhang X
    Abnormal expression of miR-136-5p in glioma cancer patients and its correlation with CT signs.
    Neurol Res. 2025 Jul 28:1-10. doi: 10.1080/01616412.2025.2532818.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.